Product Name :
APOA1(3B10-D3) monoclonal antibody Background :
ApoAI (Apolipoprotein A1) is a major component of high density lipoprotein (HDL, the “good cholesterol”) in plasma. It is produced in the liver and small intestine. ApoA1 is a cofactor for lecithin cholesterolacyltransferase (LCAT) that is responsible for the formation of plasma cholesteryl esters and promotes cholesterol efflux from tissues to the liver for excretion. Defects in ApoA1 are associated with high density lipoprotein deficiency (HDLD) and systemic non-neuropathic amyloidosis. Product :
Mouse IgG, 2mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
APOA1 monoclonal antibody detects endogenous levels of APOA1 protein. Immunogen :
Recombinant full length Human APOA1 . pathway :

• 
  1-APOA1 standard (10ug) 2-APOA1 standard（20ug）
• 
  1-APOA1 standard (10ug) 2-APOA1 standard (10ug) 3-APOA1 standard (10ug) 4-APOA1 standard (10ug) 5-APOA1 standard (10ug)

Blocking peptide available as NCP0103P